Prediction model for hyperprogressive disease in non‐small cell lung cancer treated with immune checkpoint inhibitors

BACKGROUND: Hyperprogressive disease (HPD) is a paradoxical acceleration of tumor growth after immune checkpoint inhibitor (ICI) treatment. This study aimed to identify the risk factors and to present a predictive model for HPD in patients treated with ICIs. METHODS: A total of 78 non‐small cell lun...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Thorac Cancer
Hlavní autoři: Choi, Yong Jun, Kim, Taehee, Kim, Eun Young, Lee, Sang Hoon, Kwon, Do Sun, Chang, Yoon Soo
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley & Sons Australia, Ltd 2020
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7529559/
https://ncbi.nlm.nih.gov/pubmed/32779394
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13594
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky